Systamet PG 2mg/500mg/15mg Tablet SR
Marketer
Systacare Remedies
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Systamet PG 2mg/500mg/15mg Tablet SR
GlycoBalance SR tablets (2mg/500mg/15mg) are a triple-action formulation managing blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adult type 2 diabetics. It optimizes insulin efficiency, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and schedule for GlycoBalance SR. Take with food to prevent gastric discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping may precipitate hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption to minimize the risk of adverse effects.
Primary Ingredients of Systamet PG 2mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Systamet PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Systamet PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Systamet PG 2mg/500mg/15mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.
Common Side effects of Systamet PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Systamet PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Systamet PG 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Systamet PG 2mg/500mg/15mg Tablet SR works:
Systamet PG 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct modes of action. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Systamet PG 2mg/500mg/15mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Systamet PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Systamet PG 2mg/500mg/15mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Systamet PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Systamet PG 2mg/500mg/15mg SR tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use the extended-release Systamet PG 2mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Systamet PG 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Systamet PG 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Systamet PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently